Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of oral desmopressin in children with primary nocturnal enuresis
2004-001735-37Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of desmopressin in nocturnal enuresis (NE), sponsored by Ferring Pharmaceuticals. Primary endpoint: Reduction in number of wet nights after 3 months vs baseline. Started Jan 2006; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on 2004-001735-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001735-37.